Several conventional drugs and chemical entities, mainly acting as inhibitors of the tyrosine kinase pathways, have been suggested to increase FoxO3a nuclear accumulation, thus promoting apoptosis in several cancer cell lines [21]. This evidence concerns the gene FOXO3 and cancer.